News

Keep up to date with us.

STAY
INFORMED

Find our latest news and company updates. For all media inquiries, contact us at communications@sonicincytes.com.

Categories

News Categories

LATEST NEWS

Protected: Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver Fibrosis

There is no excerpt because this is a protected post.

LATEST NEWS

Sonic Incytes Recognized at 2023 LSBC Awards Gala

Sonic Incytes was recognized as a “Company to Watch” at the 25th Annual LSBC Awards Gala, presented by Farris. This

LATEST NEWS

Sonic Incytes to Present Data at EASL International Liver Congress™️ 2023

Velacur™️ ACE Outperforms FibroScan®️ CAP for Liver Fat Quantification We are excited to announce that clinical data from Sonic Incytes’

LATEST NEWS

Sonic Incytes Receives FDA 510(k) Clearance of AI Powered Features for Velacur™️ Liver Ultrasound

Sonic Incytes is pleased to announce they have received Food and Drug Administration (FDA) clearance for new Organ Guide and

LATEST NEWS

Sonic Incytes Announces New Non-Dilutive Funding to Enhance Company’s Velacur™️ Medical Device

Sonic Incytes Medical Corp. is pleased to announce its project was selected for investment by the inaugural INOVAIT Focus Fund.

LATEST NEWS

Sonic Incytes Announces Clinical Trial Data Comparing Velacur™️ and FibroScan®

Sonic Incytes Medical Corp. is pleased to announce clinical data from a prospective multi-center study comparing the effectiveness of Velacur™️

LATEST NEWS

Sonic Incytes Announces Velacur™️ use in Madrigal Pharmaceuticals’ Open-Label Extension Clinical Trial

Sonic Incytes Medical Corp. is pleased to announce the inclusion of Velacur™️ — the first handheld 3D liver health assessment tool—in

LATEST NEWS

Sonic Incytes Receives Award at 2022 Digestive Disease Week Conference

The poster entitled “Accuracy of Velacur™️ AI Powered Liver Guide in Identification of Liver” presented at the Digestive Disease Week

LATEST NEWS

Metabolic Syndrome: Myths, Assessment Tools, Novel Treatments and More

Metabolic syndrome is a cluster of conditions that increase the risk of many chronic illnesses such as heart disease, stroke,

LATEST NEWS

Register for Novel Tools for Managing Metabolic Syndrome

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Novel Tools for Managing Metabolic Syndrome. Metabolic

LATEST NEWS

Sonic Incytes Appoints New CEO and Chair to Accelerate Growth

Following the closing of its US$7.3M Series A raise in December 2021, the Sonic Incytes Medical Corp. Board of Directors

LATEST NEWS

Sonic Incytes Successfully Completes Series A Raise of US$7.3M to Accelerate VelacurTM Commercialization

Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its

LATEST NEWS

Learn about The Power of 3D Liver Ultrasound for NASH Clinical Trials

Join us virtually on December 1 at 10AMPT/12PM CT/1PM ET at the 5th Annual NASH Summit 2021 to learn about

LATEST NEWS

Sonic Incytes Selected to Pitch at Innovative HealthTech Competition

Sonic Incytes Medical Corp. has been selected as one of three finalists at the ADA’s 2021 Silicon Valley Leaders Forum

LATEST NEWS

Register for Owning NAFLD Via Reimbursement Optimization

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Owning NAFLD Via Reimbursement Optimization. Join former

LATEST NEWS

A Master Builder of HealthTech that Matters

There is a certain thrill when you find parts and use them to build something new. For Sonic Incytes’ Lead

LATEST NEWS

VelacurTM Data Presented at 2021 AASLD The Liver Meeting

Sonic Incytes Medical Corp. is pleased to announce that data from its sponsored clinical study of VelacurTM – the first

LATEST NEWS

Sonic Incytes Showcases VelacurTM at ACG 2021

In recognition of Liver Awareness Month this October, Sonic Incytes Medical Corp. is pleased to showcase VelacurTM, the first handheld

LATEST NEWS

Join Sonic Incytes at ACG 2021

You’re invited! Join Sonic Incytes at ACG 2021. VelacurTM, the first handheld 3D liver health assessment solution, is coming to

LATEST NEWS

Discover VelacurTM at the Annual National Liver Conference

If you practice in the field of liver disease, visit our booth at the 16th Annual National Liver Conference to

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our e-newsletter.

Get in Touch

Want to find out more?